Jakavi 5 mg tablets, Jakavi 15 mg tablets
INCB 18424-270
Phase 2 small_molecule active
Quick answer
Jakavi 5 mg tablets, Jakavi 15 mg tablets for Myelofibrosis is a Phase 2 program (small_molecule) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte Biosciences Distribution B.V.
- Indication
- Myelofibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active